Production (Stage)
Opus Genetics, Inc.
IRD
$1.04
$0.044.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 41.79M | 30.32M | 36.64M | 41.41M | 47.17M |
| Total Receivables | 4.76M | 5.77M | 3.33M | 2.31M | 3.12M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.38M | 515.00K | 343.00K | 1.03M | 1.47M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 86.00K | 87.00K | 89.00K |
| Total Current Assets | 47.93M | 36.61M | 40.39M | 44.83M | 51.84M |
|
|
|||||
| Total Current Assets | 47.93M | 36.61M | 40.39M | 44.83M | 51.84M |
| Net Property, Plant & Equipment | 239.00K | 252.00K | 0.00 | 0.00 | 0.00 |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 48.17M | 36.86M | 40.39M | 44.83M | 51.84M |
|
|
|||||
| Total Accounts Payable | 2.43M | 3.15M | 844.00K | 634.00K | 2.06M |
| Total Accrued Expenses | 9.11M | 8.15M | 5.17M | 3.49M | 3.65M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 12.72M | 2.00K | 74.00K | 74.00K | 74.00K |
| Total Other Current Liabilities | 12.72M | 2.00K | 74.00K | 74.00K | 74.00K |
| Total Current Liabilities | 24.25M | 11.30M | 6.09M | 4.20M | 5.79M |
|
|
|||||
| Total Current Liabilities | 24.25M | 11.30M | 6.09M | 4.20M | 5.79M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 24.25M | 11.30M | 6.09M | 4.20M | 5.79M |
|
|
|||||
| Common Stock & APIC | 152.27M | 145.72M | 138.16M | 136.97M | 134.63M |
| Retained Earnings | -147.19M | -139.00M | -103.86M | -96.34M | -88.57M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 5.07M | 6.72M | 34.30M | 40.64M | 46.06M |
|
|
|||||
| Preferred Stock Redeemable | 18.84M | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 18.84M | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 18.84M | 18.84M | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.07M | 6.72M | 34.30M | 40.64M | 46.06M |
| Total Preferred Equity | 18.84M | 18.84M | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 23.92M | 25.57M | 34.30M | 40.64M | 46.06M |
|
|
|||||